FR2908891B1 - Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo - Google Patents

Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo

Info

Publication number
FR2908891B1
FR2908891B1 FR0758768A FR0758768A FR2908891B1 FR 2908891 B1 FR2908891 B1 FR 2908891B1 FR 0758768 A FR0758768 A FR 0758768A FR 0758768 A FR0758768 A FR 0758768A FR 2908891 B1 FR2908891 B1 FR 2908891B1
Authority
FR
France
Prior art keywords
optical imaging
diagnostic agent
vivo optical
persistent luminescence
luminescence nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0758768A
Other languages
English (en)
Other versions
FR2908891A1 (fr
Inventor
Daniel Scherman
Michel Bessodes
Corinne Chaneac
Didier Louis Gourier
Jean Pierre Jolivet
Masne De Chermont Quentin Le
Serge Maitrejean
Fabienne Julie Pelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0511113A external-priority patent/FR2892819B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0758768A priority Critical patent/FR2908891B1/fr
Publication of FR2908891A1 publication Critical patent/FR2908891A1/fr
Application granted granted Critical
Publication of FR2908891B1 publication Critical patent/FR2908891B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
FR0758768A 2005-10-28 2007-11-02 Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo Expired - Fee Related FR2908891B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0758768A FR2908891B1 (fr) 2005-10-28 2007-11-02 Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0511113A FR2892819B1 (fr) 2005-10-28 2005-10-28 Nanoparticules a luminescence persistance pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo
FR0758768A FR2908891B1 (fr) 2005-10-28 2007-11-02 Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo

Publications (2)

Publication Number Publication Date
FR2908891A1 FR2908891A1 (fr) 2008-05-23
FR2908891B1 true FR2908891B1 (fr) 2017-04-21

Family

ID=39356535

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0758768A Expired - Fee Related FR2908891B1 (fr) 2005-10-28 2007-11-02 Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo

Country Status (1)

Country Link
FR (1) FR2908891B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9757480B2 (en) 2011-01-28 2017-09-12 Abk Biomedical Incorporated Radiopaque embolic particles
FR2986332A1 (fr) 2012-01-30 2013-08-02 Centre Nat Rech Scient Nanoparticules a luminescence persistante pour l'imagerie optique en temps reel, l'imagerie multimodale optique-irm in vivo, et la theranostique
WO2016082045A1 (fr) 2014-11-26 2016-06-02 Abk Biomedical Inc. Particules de radio-embolisation
CN113353939B (zh) * 2021-05-25 2023-09-08 中国科学院上海硅酸盐研究所 一种带隙可调、降解性可控的二维氢硅烯纳米材料及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736410A (en) * 1992-09-14 1998-04-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
ES2258527T3 (es) * 2000-05-05 2006-09-01 Bayer Technology Services Gmbh Nanoparticulas impurificadas como biomarcadores.
AU2002365124A1 (en) * 2001-09-17 2003-07-09 Biocrystal, Ltd. Nanocrystals
JP3837488B2 (ja) * 2001-11-30 2006-10-25 独立行政法人産業技術総合研究所 メカノルミネッセンス材料
US20030180780A1 (en) * 2002-03-19 2003-09-25 Jun Feng Stabilized inorganic particles
DE10259935A1 (de) * 2002-12-20 2004-07-01 Bayer Ag Herstellung und Verwendung von in-situ-modifizierten Nanopartikeln

Also Published As

Publication number Publication date
FR2908891A1 (fr) 2008-05-23

Similar Documents

Publication Publication Date Title
FR2892819B1 (fr) Nanoparticules a luminescence persistance pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo
FR20C1066I2 (fr) Pièges à gdf pour l'utilisation dans le traitment de l'anémie
IL243840A0 (en) Contrast agents for myocardial perfusion imaging
IL178911A0 (en) Contrast agents for myocardial perfusion imaging
EP1883337A4 (fr) Filtre a utiliser avec des endoscopes d'imagerie
DK1593091T3 (da) Optoakustisk afbildning med høj kontrast ved anvendelse af ikke-sfæriske nanopartikler
BRPI0913492A2 (pt) "unidade de bloqueio tendo mecanismo de fechamento com linguetas multiplas"
FR2907222B1 (fr) Systeme d'inspection mobile pour vehicules
EP1893245A4 (fr) Pegylation radiomarquee de ligands destines a etre utilises comme agents d'imagerie
WO2006090389A3 (fr) Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes
NO20053354D0 (no) Optical imaging contrast agent.
FR2908891B1 (fr) Nanoparticules a luminescence persistante de type aluminate pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo
FR2880888B1 (fr) Utilisation d'aminodithiol en tant qu'agent reducteur pour la deformation permanente des cheveux
ITMI20062388A1 (it) Dispositivo per l'allineamento di ruote
IL201794A0 (en) Optical imaging agents
IL180217A0 (en) In-vivo imaging optical device
FR2921024B1 (fr) Dispositif de maintien de deverrouillage de l'articulation pour siege inclinable de vehicule
FR2916604B1 (fr) Structure porteuse pour retourneuse d'andains
FR2886921B1 (fr) Module double pour passager(s) d'aeronef
WO2008026040A3 (fr) Produits radiopharmaceutiques à base de peptides étiquetés ga
FR2919305B1 (fr) Vecteurs viraux adeno-associes pour l'expression de la dysferline.
FR2885688B1 (fr) Actionneur pour indicateurs de mesures
FR2866364B1 (fr) Dispositifs de retenue pour corps etrangers au niveau de l'evacuation de lavabos
EP1834576A4 (fr) Systeme de mesure de puissance de refraction de l'oeil
FR2931746B1 (fr) Dispositif decoratif lumineux pour piece d'habillage interieur de vehicule.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20210605